InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.14
(
-0.40%
)
Bitcoin
61,005.01
(
0.32%
)
Post# of 285925
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Theo

Send PM Follow Ignore
Followers 74
Posts 16360
Boards Moderated 3
Alias Born 04/24/2000

Theo

Member Level

Re: Theo post# 270007

Monday, 12/19/2016 9:12:36 AM

Monday, December 19, 2016 9:12:36 AM

Post# of 285925
"AB-SA01 met the trial’s primary endpoints of safety and tolerability and all nine patients enrolled in the study experienced a reduction in the quantity of S. aureus infecting their sinuses, with some patients showing complete eradication of the bacterial infection."

Hope this is not hyperbole cause this is biggly if true going forward.

Theo ;-)

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up